Triax Aesthetics

Triax Pharmaceuticals was a specialty pharmaceutical company focused on the development and commercialization of dermatological and aesthetic products. The company's portfolio primarily targeted conditions such as acne vulgaris, atopic dermatitis, and alopecia, featuring well-known brands like Tretin-X, Locoid, and Minoxidil. Headquartered in Cranford, New Jersey, Triax utilized a specialized sales force to reach dermatologists and aesthetic practitioners across the United States. In March 2012, the company's key assets were acquired by Shionogi Inc. for approximately $325 million. This acquisition allowed Shionogi to significantly expand its footprint in the US dermatology market. Prior to its acquisition, Triax was a private company backed by investors such as Kelso & Company.